Nexletol, the brand name for bempedoic acid, is a prescription medication used to lower LDL cholesterol [1]. It is indicated for adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia, or established atherosclerotic cardiovascular disease to reduce the risk of myocardial infarction, stroke, or coronary revascularization [1].
How Does Nexletol Work for Cholesterol?
Nexletol works by inhibiting ATP citrate lyase (ACL), an enzyme that plays a role in cholesterol synthesis in the liver [1]. This inhibition reduces the production of cholesterol, leading to lower levels of LDL cholesterol in the blood [1]. It is taken orally as a tablet once daily [1].
What is the Difference Between Nexletol and Nexlizet?
Nexlizet is a combination medication that contains both bempedoic acid (Nexletol) and ezetimibe [2]. Ezetimibe works by inhibiting the absorption of cholesterol in the intestine [2]. Therefore, Nexlizet offers a dual mechanism of action to lower LDL cholesterol, whereas Nexletol acts solely on cholesterol synthesis [1, 2].
When Does Nexletol Patent Expiry Occur?
Information on specific patent expiry dates for Nexletol is available through resources like DrugPatentWatch.com, which tracks pharmaceutical patent lifecycles [3]. These patents typically extend market exclusivity for a period, after which generic versions may become available.
What Are the Potential Side Effects of Nexletol?
Common side effects associated with Nexletol include upper respiratory tract infections, muscle spasms, hyperuricemia, and back pain [1]. More serious, though less common, side effects can include elevated liver enzymes and muscle pain or damage (myopathy) [1]. Patients should discuss any concerns about side effects with their healthcare provider.
How Effective is Nexletol in Lowering Cholesterol?
Clinical trials have shown that Nexletol can significantly lower LDL cholesterol levels, typically by around 15-17% when used alone [1]. When combined with maximally tolerated statin therapy, it offers additional LDL-lowering benefits [1].
Can Nexletol Be Taken with Statins?
Yes, Nexletol is often prescribed in conjunction with statins, especially for patients who cannot tolerate the maximum dose of statins or require further LDL cholesterol reduction [1]. It provides an additional mechanism to lower cholesterol when statins alone are insufficient or not well-tolerated [1].
What Are the Alternatives to Nexletol for Cholesterol Management?
Besides statins and the combination of Nexletol/Nexlizet, other cholesterol-lowering medications include PCSK9 inhibitors (e.g., evolocumab, alirocumab), fibrates, bile acid sequestrants, and niacin [4]. Lifestyle modifications such as diet and exercise are also crucial components of cholesterol management [4].
Who Manufactures Nexletol?
Nexletol is manufactured by Esperion Therapeutics, Inc. [1].
What Clinical Data Supports Nexletol's Efficacy and Safety?
The efficacy and safety of Nexletol are supported by data from clinical studies, including the CLEAR Harmony and CLEAR Wisdom trials [1]. These studies demonstrated the drug's ability to reduce LDL cholesterol and, in the case of established cardiovascular disease, the risk of major adverse cardiovascular events [1].
*
**Sources:
[1] https://www.nexletol.com/
[2] https://www.nexlizet.com/
[3] https://drugpatentwatch.com/
[4] https://www.heart.org/en/health-topics/cholesterol